As we previously blogged, on April 16, 2020, The Nasdaq Stock Market (“Nasdaq”) announced temporary relief from the bid price and market value of publicly-held shares listing requirements in response to the COVID-19 pandemic. In addition, on May 1, 2020, Nasdaq adopted Nasdaq Rule 5636T, which provided an exception from certain shareholder approval rules for companies impacted by the COVID-19 pandemic. Nasdaq recently confirmed that the temporary relief and the exceptions provided by Rule 5636T…

US reporting companies that are planning or have completed a significant acquisition of a business may be required to file separate target financial statements and related pro forma financial statements under Rule 3-05 and Article 11 of Regulation S-X.  The specific US Securities and Exchange Commission rules and financial reporting obligations triggered by a significant acquisition can be quite complex, requiring careful evaluation by an acquiring company.  This note discusses the SEC’s financial reporting and…

Sunday, July 19, 2020 9:00 a.m. – 10:00 a.m. EDT 4:00 p.m. – 5:00 p.m. Israel Time Register here Join Mayer Brown and PwC for a webinar on Life Sciences IPOs.  Panelists will discuss the pre-IPO and IPO markets and IPO preparedness, among other topics. CEO and Co-Founder of InMode, Moshe Mizrahy, will join our panel, and give an insider’s perspective on the IPO process. Speakers Omer Gavish, Partner, Pharma & Life Sciences Leader, PwC…

On July 2, 2020, the Securities and Exchange Commission (the “SEC”) approved, with immediate effectiveness, the New York Stock Exchange’s (“NYSE”) proposal to extend its waiver of the shareholder approval requirements set forth in Section 312.03 of the NYSE Listed Company Manual through September 30, 2020.  As we previously blogged, the SEC initially approved the NYSE’s waiver of such requirements through June 30, 2020.  In the proposal, the NYSE noted that a number of listed…

July 16-17, 2020 Register here This two day program will provide an in-depth review of the basic aspects of the U.S. federal securities laws. Emphasis will be placed on the interplay among the Securities Act of 1933, the Securities Exchange Act of 1934, the Sarbanes-Oxley Act, the Dodd-Frank Act, the JOBS Act, the securities-related provisions of the FAST Act, related SEC regulations and significant legislative and regulatory changes and proposals. Partner Anna Pinedo will co-lead…

This market trends article identifies cybersecurity risk disclosures that offer detailed discussions on the potential reputational, financial, or operational harm resulting from cybersecurity breaches and the potential litigation or regulatory costs, policies, and procedures in addressing cybersecurity risks. This article concludes with practical advice on how to prepare and enhance the required disclosures on cybersecurity risks and incidents. Continue reading.…

PLI Webinar July 9, 2020 1:00 pm- 2:00 pm EDT Register here Many smaller public companies seek access to financing through equity line financing arrangements.  Equity line transactions often are confused with continuous offerings that are structured as at the market offering programs.  Each financing alternative has distinct characteristics, and differ in important respects.  During this webcast, the speakers will discuss the following: Basic structure of an equity line; public versus private SEC’s historic analysis…